Summary
T- and K-cell cytotoxic activity has been measured in groups of type I diabetic patients and comparable groups of healthy control subjects. The mean cytotoxic indices for T-cell activity were 0.72 for 13 type I diabetics and −2.38 for a control group. These values are not significantly different. K-cell cytotoxic activity was measured using both chicken red blood cells and Chang liver cells coated with appropriate xenogenic antibodies. Using the chicken red blood cell system the percentage specific chromium release was 55.3 for 17 type I diabetics and 50.0 for a control group. These values are not significantly different. Using the Chang liver cell system the percentage specific chromium release was 13.9 for 37 type I diabetics and 9.7 for a control group. This difference is statistically significant (p<0.05).
Similar content being viewed by others
References
Asplin C. M., Hartog M., Goldie D. J.: Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin — Diabetologia14, 99, 1978.
Bottazzo G. F., Dean B. M., Gorsuch A. N., Cudworth A. G., Doniach D.: Complement-fixing islet-cell antibodies in type I diabetes: possible monitors of active beta-cell damage — Lanceti, 668, 1980.
Bottazzo G. F., Mann J. I., Thorogood M., Baum J. D., Doniach D.: Autoimmunity in juvenile diabetics and their families — Brit. med. J.ii, 165, 1978.
Berson S. A., Yalow R. S.: Quantative aspects of the reaction between insulin and insulin binding antibody — J. clin. Invest.38, 1996, 1959.
Berson S. A., Yalow R. S.: The present state of insulin antagonists in plasma — Diabetes13, 247, 1964.
Bruni B., Gamba S., Regis G., Turco G. L.: Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment — Diabetologia14, 165, 1978.
Calder E. A., Irvine W. J., Davidson M. D., Wu F.: T-, B- and K-cells in autoimmune thyroid disease — Clin. exp. Immunol.25, 17, 1976.
Cudworth A. G.: Diabetes — the possible aetiological role of viruses. In:Heath R. B. (Ed.): Virus diseases. Pitman Medical, Tunbridge Wells, 1979; p. 59.
Cudworth A. G.: Type I diabetes mellitus — Diabetologia14, 281, 1978.
Di Mario U., Iavicoli M., Andreani D.: Circulating immune complexes in diabetes — Diabetologia19, 89, 1980.
Galama J. M. D., Vos A., Lucas C. J.: Lymphocyte-mediated cytotoxicity to autologous cells infected with measles virus. II. Specificity of the cytotoxic reaction and characterization of the effector cells involved — Cell. Immunol.48, 296, 1979.
Gepts W.: Pathological anatomy of the pancreas in juvenile diabetes mellitus — Diabetes14, 613, 1966.
Heding L. G., Larsson Y., Ludvigsson J.: The immunogenicity of insulin preparation. Antibody levels before and after transfer to highly purified porcine insulin — Diabetologia19, 511, 1980.
Huang S. W., MacLaren N. K.: Insulin dependent diabetes: a disease of autoaggression — Science192, 94, 1976.
Iavicoli M., Di Mario U., Pozzilli P., Canalese J., Ventriglia L., Galfo C., Andreani D.: Impaired phagocytic function and increased immune complexes in diabetics with severe microangiopathy — Diabetes31, 7, 1982.
Junker K., Egeburg J., Kromann H.: An autopsy study of the islets of Langerhans in acute onset juvenile diabetes mellitus — Acta path. microbiol. scand.85 (A), 699, 1977.
Kohl S., Pickering L. K., Diluzio N. R.: Inhibition of human monocyte macrophage and lymphocyte cytotoxicity to herpes simplex-infected cells by glucan — J. immunol. Meth.29, 361, 1979.
Koide Y., Takasugi M.: Determination of specificity in natural cell cytotoxicity by natural antibodies — J. nat. Cancer Inst.59, 1099, 1977.
Kreth H. W., Wiegand G.: Cell mediated cytotoxicity against measles virus in SSPE. II. Analysis of cytotoxic effector cells — J. Immunol.118, 296, 1977.
Kurtz A. B., Matthews J. A., Mustaffa E. B., Daggett P. R., Nabarro J. D. N.: Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin — Diabetologia18, 147, 1980.
Lernmark Å., Freedman Z. R., Hoffman C., Rubenstein A. H., Steiner D. F., Jackson R. L., Winter R. J., Traisman H. S.: Islet cell surface antibodies in juvenile diabetes mellitus — New Engl. J. Med.299, 375, 1978.
Murray R. K., Suss R., Pitot H. C.: Isolation and characterization of cytoplasmic components of cancer cells — Meth. Cancer Res.ii, 244, 1967.
Nelson D. L., Bundy B. M., Pitchon N. E., Blaese R. M., Stroker W.: The effector cells in human peripheral blood mediating in mitogen-induced cellular toxicity and antibody-dependent cellular toxicity. — J. Immunol.117, 1472, 1976.
Ortaldo J. R., MacDermott R. P., Bonnard G. D., Kind P. D., Heberman R. B.: Cytotoxicity from cultured cells: analysis of precursors involved in the generation of human cells mediating natural and antibody-dependent cell-mediated cytotoxicity — Cell. Immunol.48, 356, 1979.
Perlmann P., Perlmann P., Wigzell H.: Lymphocyte mediated cytotoxicityin vitro. Induction and inhibition by humoral antibody and nature of effector cells — Transplant. Rev.13, 91, 1972.
Podleski N. K.: Cytotoxic lymphocytes in Hashimoto thyroiditis — Clin. exp. Immunol.11, 543, 1972.
Pozzilli P., Sensi M., Gorsuch A., Bottazzo G. F., Cudworth A. G.: Evidence for raised K-cell levels in type I diabetes — Lancetii, 173, 1979.
Rittenhouse H. G., Oxender D. L., Pek S., Ar D.: Complement-mediated cytotoxic effects on pancreatic islets with sera from diabetic patients — Diabetes29, 317, 1980.
Sensi M., Pozzilli P., Gorsuch A. N., Bottazzo G. F., Cudworth A. G.: Increased killer cell activity in insulin dependent (type 1) diabetes mellitus — Diabetologia20, 106, 1981.
Zeijlemaker W. P., van Oers M. H. J., de Goede R. E. Y., Schellekens P. Th: Cytotoxic activity of human lymphocytes: quantitative analysis of T-cell and K-cell cytotoxicity serial enzyme like kinetics — J. Immunol.119, 1507, 1977.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Richens, E.R., Quilley, J. & Hartog, M. An investigation into cytotoxic mechanisms in type I diabetes mellitus. Acta diabet. lat 19, 329–337 (1982). https://doi.org/10.1007/BF02629255
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02629255